NCT02644109 Effect On Serum Cholesterol Of Dairy Products With Addition Of Esterified Phytosterols Status COMPLETED Phase PHASE4
NCT02634606 Effects of a Supplement Derived From Palm Oil on Cholesterol Levels in the Blood Status TERMINATED Phase PHASE3
NCT02634580 Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-4 Status COMPLETED Phase PHASE3
NCT02609295 Effects of α-linolenic Acid Supplementation on Hemostasis in Nondiabetic and Hypercholesterolemic Subjects Status COMPLETED Phase PHASE3
NCT02608697 A Study to Assess the Safety and Efficacy of CAT-2054 in Combination With Atorvastatin in Patients With Hypercholesterolemia Status COMPLETED Phase PHASE2
NCT02603276 Lipid-lowering Effect of Phytosterols, Red Yeast Rice and Their Combination Status COMPLETED Phase NA
NCT02591836 Efficacy and Safety of Gemcabene in Hypercholesterolemic Patients as Monotherapy or in Combination With Atorvastatin Status COMPLETED Phase PHASE2
NCT02587390 Effect of Gemcabene on the Pharmacokinetics of Simvastatin in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02587364 Pharmacokinetics and Pharmacodynamics Study of Gemcabene in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02585895 Evolocumab Compared to LDL-C Apheresis in Patients Receiving LDL-C Apheresis Prior to Study Enrollment Status COMPLETED Phase PHASE3
NCT02585869 Efficacy and Safety of Gemcabene in Patients With Low HDL-C and Either Normal or Elevated Triglycerides Status COMPLETED Phase PHASE2
NCT02584504 Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid Modifying Therapy or the Lowest Strength of Statin Status COMPLETED Phase PHASE3
NCT02579655 Assessing Outcomes of Enhanced Chronic Disease Care Through Patient Education and a Value-based Formulary Study Status COMPLETED Phase NA
NCT02571257 Efficacy and Safety of Gemcabene in Hypercholesterolemic Patients on Stable Statin Therapy Status COMPLETED Phase PHASE2
NCT02550288 A Clinical Trial to Assess the Efficacy and Safety of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-383) Status COMPLETED Phase PHASE3
NCT02508896 Study Assessing Safety, Immunogenicity and LDLc -Lowering Activity of 2 PCSK9 Targeting AFFITOPE Vaccines in Healthy Subjects Status COMPLETED Phase PHASE1